(Q40533389)

21 September 2017

title

Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia (English)

1 reference

21 September 2017

Antonio Jimeno

1

1 reference

21 September 2017

Adelaida García-Velasco

2

1 reference

21 September 2017

Olga del Val

3

1 reference

21 September 2017

Enrique González-Billalabeitia

4

1 reference

21 September 2017

Susana Hernando

5

1 reference

21 September 2017

Rosario Hernández

6

1 reference

21 September 2017

Alfonso Sánchez-Muñoz

7

1 reference

21 September 2017

Ana López-Martín

8

1 reference

21 September 2017

Ignacio Durán

9

1 reference

21 September 2017

Luis Robles

10

1 reference

21 September 2017

Hernán Cortés-Funes

11

1 reference

21 September 2017

Luis Paz-Ares

12

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

100

1 reference

21 September 2017

issue

11

1 reference

21 September 2017

page(s)

2462-2469

1 reference

Kinetics of procalcitonin in iatrogenic sepsis

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

The complete sequence of human preprocalcitonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Pathobiochemistry and clinical use of procalcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Induction of procalcitonin and proinflammatory cytokines in an anhepatic baboon endotoxin shock model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Molecular aspects and natural source of procalcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Procalcitonin concentrations in patients with neutropenic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Duration of empiric antibiotic therapy in granulocytopenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Could procalcitonin be a predictive biological marker in systemic fungal infections?. Study of 14 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

High serum procalcitonin concentrations in patients with sepsis and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Outcome prediction by traditional and new markers of inflammation in patients with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Procalcitonin as a marker of severity in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Procalcitonin used as a marker of infection in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

inferred from DOI database lookup

7 January 2021

based on heuristic

Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

inferred from DOI database lookup

7 January 2021

based on heuristic

New trends in patient management: risk-based therapy for febrile patients with neutropenia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20275

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.20275

1 reference

21 September 2017

1 reference